Background
==========

*Brucella*spp. are Gram-negative, non-motile, facultative intracellular bacterial pathogens that are the etiologic agents of brucellosis, causing abortion and sterility in a broad range of domestic and wild animals. Furthermore, brucellosis is a chronic zoonotic disease characterized in humans by undulant fever, arthritic pain and neurological disorders. *Brucella*virulence relies upon the ability to enter phagocytic and non-phagocytic cells, control the host\'s intracellular trafficking to avoid lysosomal degradation, and replicate in a *Brucella*-containing vacuole (brucellosome) without restricting host cell functions or inducing programmed death \[[@B1]-[@B3]\]. Although a few genes are directly attributed to the survival and intracellular trafficking of *Brucella*in the host cell (e.g., cyclic β-(1,2) glucan, lipopolysaccharide and the type IV secretion system (T4SS)), many aspects of the intracellular lifestyle remain unresolved \[[@B4]-[@B6]\].

Quorum sensing (QS), a communication system of bacteria, has been shown to coordinate group behavior in a density dependent manner by regulating gene expression; including secretion systems, biofilm formation, AI production, and cell division \[[@B7]-[@B10]\]. QS typically follows production of a diffusible signaling molecule or autoinducer (AI) acyl-homoserine lactone (AHL). Among proteobacteria, the larger family to which *Brucella*belong, the AHL signal is synthesized by *luxI*, and shown to interact with the transcriptional regulator LuxR to cooperatively modulate gene expression \[[@B9]\]. In addition to an AHL signal, LuxR regulatory activity can be modulated by phosphorylation (*fixJ*), contain multiple ligand binding sites (*malT*), or LuxR can function as an autonomous effector without a regulatory domain (*gerE*) \[[@B11]-[@B13]\].

Two LuxR-like transcriptional regulators, VjbR and BlxR (or also referred to as BabR) have been identified in *Brucella melitensis*\[[@B14],[@B15]\]. VjbR was shown to positively influence expression of the T4SS and flagellar genes, both of which contribute to *B. melitensis*virulence and survival \[[@B14]\]. Although an AHL signal *N-*dodecanoyl homoserine lactone (C~12~-HSL) has been purified from *Brucella*culture supernatants, the gene responsible for the production of this AHL (*luxI*) has not yet been identified \[[@B16]\]. One possible explanation for the apparent absence of *luxI*homologues is that *Brucella*contains a novel AHL synthetase that remains to be identified. The fact that both LuxR homologues respond to C~12~-HSL by altering the expression of virulence determinants is also consistent with a role for the autoinducer in regulating expression of genes necessary for intracellular survival \[[@B17],[@B18]\]. Specifically, expression of the *virB*and *flgE*operons are repressed by the addition of exogenous C~12~-HSL \[[@B14],[@B16]\]. The results reported here extend those observations and suggest that C~12~-HSL acts as a global repressor of gene expression via interaction with VjbR while functioning to activate expression of other loci independent of VjbR.

In the present study, we sought to identify additional regulatory targets of the putative QS components VjbR and C~12~-HSL in an effort to identify novel virulence factors to confirm a role for QS in intracellular survival. Custom *B. melitensis*70-mer oligonucleotide microarrays were utilized to characterize gene expression. Comparison of transcript levels from *B. melitensis*wildtype and a *vjbR*deletion mutant, with and without the addition of exogenous C~12~-HSL revealed a large number of genes not previously shown to be regulated in *B. melitensis*, including those involved in numerous metabolic pathways and putative virulence genes (e.g., adhesins, proteases, lipoproteins, outer membrane proteins, secretion systems and potential effector proteins). Additionally, results confirmed earlier findings of genes regulated by these components, validating the microarray approach for identification of genes that may contribute to intracellular survival and virulence.

Methods
=======

Bacteria, macrophage strains and growth conditions
--------------------------------------------------

*Escherichia coli*DH5α™-T1^R^competent cells were used for cloning and routinely grown on Luria-Bertani (LB, Difco Laboratories) overnight at 37°C with supplemental kanamycin (100 mg/l) or carbenicillin (100 mg/l) as needed. *B. melitensis*16M was grown on tryptic soy agar or broth (TSA or TSB) and J774A.1 murine macrophage-like cells were maintained in T-75 flasks in Dulbecco\'s modified Eagle\'s medium, HEPES modification (DMEM), supplemented with 1× MEM non-essential amino acids (Sigma, St Louis, MO), 0.37% sodium bicarbonate and 10% fetal bovine serum at 37°C with 5% CO~2~. All work with live *B. melitensis*was performed in a biosafety level 3 laboratory at Texas A&M University College Station, per CDC approved standard operating procedures. All bacterialstrains used are listed in Additional File [1](#S1){ref-type="supplementary-material"}, Table S1.

Generation of gene replacement and deletion mutants
---------------------------------------------------

LuxR-like proteins were identified in *B. melitensis*using NCBI BLAST protein homology searches <http://www.ncbi.nlm.nih.gov/>. *B. melitensis*16M *luxR*gene replacement and deletion mutations were created as previously described by our laboratory, with plasmids and strains generated described in Additional File [1](#S1){ref-type="supplementary-material"}, Table S1 and primers for PCR applications listed in Additional File [2](#S2){ref-type="supplementary-material"}, Table S2 \[[@B19]\]. For complementation of the Δ*vjbR*mutation, gene locus BMEII1116 was amplified by PCR primers TAF588 and TAF589, cloned into pMR10-Kan *Xba*I sites, and electroporated into *B. melitensis*16MΔ*vjbR*(Additional File [1](#S1){ref-type="supplementary-material"}, Table S1 and Additional File [2](#S2){ref-type="supplementary-material"}, Table S2).

Gentamycin protection assay
---------------------------

J774A.1 cells were seeded into 24-well plates at a density of 2.5 × 10^5^CFU/well and allowed to rest for 24 hours in DMEM. J774A.1 cells were infected with *B. melitensis*16M or mutant strains in individual wells at an MOI of 20. Following infection, monolayers were centrifuged (200 × g) for 5 min and incubated for 20 minutes. Infected monolayers were washed 3 × in Peptone Saline (1% Bacto-Peptone and 0.5% NaCl), and incubated in DMEM supplemented with gentamycin (40 μg/ml) for 1 hour. To collect internalized bacteria at time 0 and 48 hours post-infection, macrophages were lysed in 0.5% Tween-20 and serial dilutions were plated to determine bacterial colony forming units (CFU).

RNA collection
--------------

Cultures were grown in *Brucella*Broth at 37°C with agitation. Cultures for the AHL experiments were grown with the addition of exogenous *N*-dodecanoylhomoserine lactone (C~12~-HSL, Sigma, St. Louis, MO) added at inoculation (50 ng/ml) dissolved in DMSO (at a final concentration of 0.008%) \[[@B16]\]. Total RNA was extracted at mid-exponential (OD~600~= 0.4) and early stationary (OD~600~= 1.5) growth phases by hot acidic phenol extraction, as previously described \[[@B20]\]. Contaminating DNA was degraded by incubation with DNAseI (Qiagen, Valencia, CA) following manufacturer\'s instructions and purified using the HighPure RNA isolation kit (Roche, Indianapolis, IN). RNA integrity, purity and concentration were evaluated using a 2100 bioanalyzer (Agilent, Santa Clara CA), electrophoresis, and the Nanodrop^®^ND-1000 (Nanodrop, Wilmington, DE).

DNA and RNA labeling for microarrays
------------------------------------

*B. melitensis*16M genomic DNA was processed into cDNA using the BioPrime^®^Plus Array CGH Indirect Genomic Labeling System (Invitrogen, Carlsbad, CA) and purified using PCR purification columns (Qiagen, Valencia, CA) following the manufacturer\'s instructions and eluted in 0.1× of the supplied elution buffer.

The cDNA synthesis from total RNA was produced using SuperScript III reverse transcriptase kit following manufacturer instructions (Invitrogen, Carlsbad, CA). Reactions were subsequently purified with PCR Purification columns (Qiagen, Valencia, CA) using a modified wash (5 mM KPO~4~(pH 8.0) and 80% ethanol) and incremental elution with 4 mM KPO~4~, pH 8.5. Alexa-Fluor 555 (Invitrogen, Carlsbad, CA) was coupled to the RNA-derived cDNA following the procedure outlined in the BioPrime^®^Plus Array CGH Indirect Genomic Labeling System (Invitrogen, Carlsbad, CA) and purified using PCR purification columns (Qiagen, Valencia, CA). Labeled RNA samples were dried completely and re-suspended in ddH~2~O immediately before hybridization to the microarrays.

Microarray construction
-----------------------

Unique 70-mer oligonucleotides (Sigma, St. Louis, MO) representing 3,227 ORFs of *B. melitensis*16M and unique sequences from *B. abortus*and *B. suis*were suspended in 3× SSC (Ambion, Austin, TX) at 40 μM. The oligonucleotides were spotted in quadruplicate onto ultraGAP glass slides (Corning, Corning, NY) by a custom-built robotic arrayer (Magna Arrayer) assembled at Dr. Stephen A. Johnston\'s lab at the University of Texas Southwestern Medical Center (Dallas, TX). The printed slides were steamed, UV cross-linked, and stored in a desiccator until use.

Microarray pre-hybridization, hybridization and washing
-------------------------------------------------------

Printed slides were submerged in 0.2% SDS for 2 minutes and washed 3× in ddH~2~O before incubation in prehybridization solution (5× SSC, 0.1% SDS and 1% BSA) at 45°C for 45 minutes. Next, slides were washed 5× in ddH~2~O, rinsed with isopropanol, and immediately dried by centrifugation at 200 × g for 2 minutes at room temperature. The labeled cDNA mix was combined with 1× hybridization buffer (25% formamide, 1× SSC and 0.1%SDS) and applied to the microarray in conjunction with a 22 × 60 mm LifterSlip (Erie Scientific, Portsmouth, NH). The microarray slides were hybridized at 42°C for approximately 21 hours in a sealed hybridization chamber with moisture (Corning, Corning, NY), and subsequently washed at room temperature with agitation in 2× SSC and 0.2% SDS (pre-heated to 42°C) for 10 minutes, 5 minutes in 2× SSC, followed by 0.2× SSC for 5 minutes, and dried by centrifugation for 2 minutes (200 × g) at room temperature.

Microarray data acquisition and analysis
----------------------------------------

Array slides were scanned using GenePix 4100A (Molecular Devices, Sunnyvale, CA) and GenePix 6.1 Pro software. Seralogix, Inc. (Austin, TX) performed microarray analysis, normalizing the data and identifying differentially expressed genes by a two-tail z-score level greater than ± 1.96, equating to a confidence level of 95%. Additionally, the NIH/NIAID WRCE bioinformatics core performed microarray analysis as follows: GeneSifter (VizX Labs, Seattle, WA) was used to perform normalization based on the global mean and genes with alterations of least a 1.5-fold, with a *p*value of 0.05 or less based on Student\'s *t*-test were deemed as statistically significant. Any gene that was considered statistically significant based on Student\'s *t*-test but not by the z-score criteria were further expected to be at least 50% greater in magnitude (e.g., 1.5-fold greater) than the fold-change observed between any two biological replicate samples. All gene expression data have been deposited in NCBI\'s Gene Expression Omnibus and are accessible through GEO Series accession number GSE13634.

Quantitative real time PCR
--------------------------

Taqman^®^universal probes and primer pairs (Additional File [2](#S2){ref-type="supplementary-material"}, Table S2) were selected using Roche\'s Universal Probe Library and probefinder software <http://www.universalprobelibrary.com>. RNA was reverse transcribed to cDNA using the Transcriptor First Strand cDNA synthesis kit (Roche, Indianapolis, IN) andPCR reactions consisted of 1× TaqMan^®^universal PCR master mix, no AmpErase^®^UNG (Applied Biosystems, Foster City, CA), 200 nM of each primer and 100 nM of probe. With the exception of BMEI1758, genes were selected at random for quantitative real time PCR (qRT-PCR) verification, and were performed in triplicate for each sample within a plate and repeated 3× using the 7500 Real Time PCR System (Applied Biosystems, Foster City, CA). Gene expression was normalized to that of 16s rRNA and the fold-change calculated using the comparative threshold method \[[@B21]\].

Screen for a putative AHL synthase
----------------------------------

Fifteen *B. melitensis*genetic loci and *P. aeruginosa lasI*and *rhlI*were amplified by PCR, cloned into *BamH*I sites in the pET-11a expression vector and transformed by heat-shock into *E. coli*BL21-Gold(DE3) cells (Additional File [1](#S1){ref-type="supplementary-material"}, Table S1 and Additional File [2](#S2){ref-type="supplementary-material"}, Table S2). The resulting clones were cross streaked on LB agar supplemented with 2 mM IPTG with *E. coli*JLD271 + pAL105 and pAL106 for detection of C~12~-HSL production, and *E. coli*JLD271 + pAL101 and pAL102 for detection of C~4~-HSL production (Additional File [1](#S1){ref-type="supplementary-material"}, Table S1). Cross-streaks were incubated at 37°C for 2-8 hours, and luminescence was detected using the FluorChem Imaging System (Alpha-Innotech, San Leandro, CA) at varied exposure times.

Results and Discussion
======================

Identification and screening for attenuation of Δ*luxR*mutants in J774A.1 macrophage-like cells
-----------------------------------------------------------------------------------------------

A *luxR*-like gene, *vjbR*, was identified in a mutagenesis screen conducted by this laboratory and others \[[@B22]\]. More recently, a second *luxR-*like gene, *blxR*(or *babR*), has also been identified and characterized \[[@B15],[@B23]\]. These two homologues, VjbR and BlxR, contain the two domains associated with QS LuxR proteins (i.e., autoinducer binding domain and LuxR DNA binding domain). BLAST protein homology searches with the LuxR-like proteins identified three additional proteins that contain significant similarity to the LuxR helix-turn-helix (HTH) DNA binding domain but do not contain the AHL binding domain. All 5 *B. melitensis*LuxR-like proteins exhibit similar levels of relatedness to *Agrobacterium tumefaciens*TraR homolog (29-34%) and canonical LuxR homolog LasR from *Pseudomonas aeruginosa*(29-43%). Despite the absence of a characterized activation domain, evaluation of these three proteins was pursued due to their similarity with LuxR homologs best characterized in *Vibrio harveyi*that act autonomously or via phosphorylation/dephosphorylation to alter gene expression from selected loci \[[@B24],[@B25]\].

Gene replacement and deletion mutations were created for all five homologues including the three newly discovered HTH LuxR DNA binding domain homologues (BME I1582, I1751 and II0853), *vjbR*, and *blxR*in *B. melitensis*16M and survival in J774A.1 macrophage-like cells was subsequently assessed by gentamycin protection assays. Confirming previous findings, intracellular survival was significantly reduced for both the *vjbR*transposon and deletion mutants and not for the *blxR*mutant, as indicated by CFU recovery after 48 hrs of infection (Fig. [1](#F1){ref-type="fig"}) \[[@B14],[@B23]\]. Survival of the *vjbR*mutant was restored to nearly wildtype levels after complementation (Fig. [1](#F1){ref-type="fig"}). No significant difference in CFU was observed for the other three mutants when compared to wildtype infected cells, indicating that these homologues are either not required for intracellular replication in macrophages or there is functional redundancy among some of homologues (Fig. [1](#F1){ref-type="fig"}). A recent report presented evidence indicating that the Δ*blxR*and Δ*vjbR*mutants exhibited similar levels of attenuated intracellular survival in the RAW264.7 macrophage cells \[[@B15]\]. However, the Δ*blxR*mutant proved to be virulent in IRF1-/- knockout mice, with only a slight delay in mortality when compared to wildtype (10 days vs. 7.4, respectively) \[[@B15]\]. For comparison, all of the mice inoculated with the Δ*vjbR*mutant survived to at least day 14 \[[@B15]\]. Taken together the results suggest that the loss of *blxR*expression has only a modest effect on virulence/survival and the attenuated phenotype of the Δ*vjbR*mutant is more consistently observed.

![**Intracellular survival of *B. melitensis*16M (wt), *vjbR*mutant (Δ*vjbR*and *vjbR*::m *Tn*5), complemented Δ*vjbR*(Δ*vjbR*comp and Δ*vjbRvector*), Δ*blxR*mutant, and 3 additional *luxR*-like mutants in J774A.1 murine macrophage-like cells**. The attenuation was measured as the log difference between the CFU recoveries of the mutant compared to wildtype from infected macrophages at 48 hours post infection. Data shown is the averaged CFU recovery from at least 3 independent experiments, each performed in triplicate. Error bars represent the SEM and each mutant was compared to the wildtype by a Student\'s two tailed *t*-test, with the resulting *p*values as follows:\*, *P*\< .0.05; \*\*\*, *P*\< 0.001. The *luxR*deletion mutant strains are identified by the BME gene locus ID tags, BME::Km representing the gene replacement mutant and ΔBME representing the gene deletion mutant.](1471-2180-10-167-1){#F1}

Microarray analysis indicates that *Brucella*putative quorum sensing components are global regulators of gene expression
------------------------------------------------------------------------------------------------------------------------

To investigate the transcriptional effects resulting from a *vjbR*deletion and the addition of exogenous C~12~-HSL, RNA was isolated from wildtype *B. melitensis*16M, the isogenic Δ*vjbR*, and both strains with the addition of exogenous C~12~-HSL, at a logarithmic growth phase and an early stationary growth phase. The use of exogenous C~12~-HSL addition to cultures was selected because of the inability to eliminate the gene(s) responsible for C~12~-HSL production. Three independent RNA samples were harvested at each time point (exponential and early stationary growth phases) and hybridized with reference genomic DNA, which yielded a total of 24 microarrays.

Microarray analysis revealed a total of 202 (Fig. [2A](#F2){ref-type="fig"}, blue circles) and 229 genes (Fig. [2B](#F2){ref-type="fig"}, blue circles) to be differentially expressed between wildtype and Δ*vjbR*cultures at exponential and stationary growth phases, respectively (details provided in Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). This comprises 14% of the *B. melitensis*genome and is comparable to the value of 10% for LuxR-regulated genes previously predicted for in *P. aeruginosa*\[[@B26]\]. The majority of altered genes at the exponential phase were down-regulated (168 genes) in the absence of *vjbR*, while only 34 genes were up-regulated (Fig. [2A](#F2){ref-type="fig"}, blue circles). There were also a large number of down-regulated genes (108 genes) at the stationary phase; however, at this later time point there were also 121 genes that were specifically up-regulated (Fig. [2B](#F2){ref-type="fig"}, blue circles). When comparing wild-type cells with and without the addition of exogenous C~12~-HSL, the majority of genes were found to be down-regulated at both growth phases, 249 genes at exponential phase (Fig. [2A](#F2){ref-type="fig"}, green circle) and 89 genes at stationary phase (Fig. [2B](#F2){ref-type="fig"}, green circle). These data suggest that VjbR is primarily a promoter of gene expression at the exponential growth phase and acts as both a transcriptional repressor and activator at the stationary growth phase. Conversely, C~12~-HSL primarily represses gene expression at both growth phases.

![**Numbers and relationships of transcripts altered by the deletion of *vjbR*and/or treatment of C**~12~**-HSL**. Numbers represent the statistically significant transcripts found to be up or down-regulated by microarray analysis at the A) exponential growth phase (OD~600~= 0.4) and B) stationary growth phase (OD~600~= 1.5).](1471-2180-10-167-2){#F2}

Quantitative real time PCR (qRT-PCR) was performed to verify the changes in gene expression for 11 randomly selected genes found to be altered by the microarray analyses (Table [1](#T1){ref-type="table"}). For consistency across the different transcriptional profiling assays, cDNA was synthesized from the same RNA extracts harvested for the microarray experiments. For the 11 selected genes, the relative transcript levels were comparable to the expression levels obtained from the microarray data.

###### 

Quantitative real time PCR and corresponding microarray data of selected genes.

  ----------------------------------------------------------------------------------------------------------------------------
  BME\      Gene Function\                                                 Condition (growth phase)\   Change (Fold)\   
  Loci                                                                                                                  
  --------- -------------------------------------------------------------- --------------------------- ---------------- ------
  I 0984    ABC-Type β-(1,2) Glucan Transporter                            Δ*vjbR*/wt (ES)             -2.5             -2.1

  II 0151   Flagellar M-Ring Protein, FliF                                 Δ*vjbR*/wt (ES)             -7.9             -2.2

  II 1069   Adhesin, AidA                                                  Δ*vjbR*/wt (SP)             -1.9             -1.5

  I 0561    Membrane-Bound Lytic Murein Transglycosylase B                 Δ*vjbR*/wt (SP)             -1.7             -2.0

  II 0025   Attachment Mediating Protein VirB1                             Δ*vjbR*/wt (SP)             -4.1             -2.6

  I 0831    UDP-3-O-\[3-hydroxymyristoyl\] Glucosamine N-Acyltransferase   wt + AHL/wt (ES)            2.2              2.3

  II 0151   Flagellar M-Ring Protein, FliF                                 wt + AHL/wt (ES)            -3.8             -2.1

  II 0838   Succinoglycan Biosynthesis Transport Protein, ExoT             wt + AHL/wt (ES)            -1.7             -4.3

  II 1116   LuxR Family Transcriptional Regulator, VjbR                    wt + AHL/wt (SP)            -2.9             \-

  I 1758    LuxR Family Transcriptional Regulator, BlxR                    wt + AHL/wt (SP)            27.5             \-

  I 0155    Putative Allantoin Permease                                    wt + AHL/wt (SP)            -1.7             -1.4

  II 0025   Attachment Mediating Protein VirB1                             wt + AHL/wt (SP)            -2.5             -2.2

  II 0753   ABC-Type Sorbitol/Mannitol Transport Inner Membrane Protein    Δ*vjbR*/Δ*vjbR*+ AHL (ES)   1.5              2.5

  I 1758    LuxR Family Transcriptional Regulator, BabR                    Δ*vjbR*/Δ*vjbR*+AHL (SP)    99.5             \-
  ----------------------------------------------------------------------------------------------------------------------------

A (-) indicates genes excluded for technical reasons or had a fold change of less than 1.5. qRT-PCR values were calculated by the ΔΔCt method normalized to 16s rRNA and are relative to the wildtype, averaged from 3 independently isolated samples, performed in triplicate in a minimum of three assays. ES, Exponential growth phase; SP, Stationary growth phase.

Recently, a *virB*promoter sequence was identified and confirmed to promote expression of downstream genes via VjbR \[[@B27]\]. With such a large number of transcriptional regulators found to be altered downstream of VjbR and by the addition of C~12~-HSL (Table [2](#T2){ref-type="table"}), it is plausible that many of the gene alterations observed may be downstream events and not directly regulated by VjbR. To identify altered genes that are likely directly regulated by VjbR, microarray data from these studies were compared to the potential operons downstream of the predicted VjbR promoter sequences \[[@B27]\]. A total of 91 potential operons from the 144 previously predicted VjbR promoter sequences were found to be altered by a deletion of VjbR and/or treatment of wildtype cells with C~12~-HSL, comprised of 215 genes (Additional File [4](#S4){ref-type="supplementary-material"}, Table S4) \[[@B27]\]. A total of 11 promoters from the confirmed 15 found to be activated by VjbR in an *E. coli*model were identified in the microarray analyses conducted in this study, confirming the direct regulation of these particular operons (Additional File [4](#S4){ref-type="supplementary-material"}, Table S4) \[[@B27]\].

###### 

Transcripts associated with gene regulation significantly altered between 16M and 16MΔ*vjbR*, with and without the treatment of C~12~-HSL to cells.

  BME Loci   Gene Function                            Exponential Growth Phase Change (fold)   Stationary Growth Phase Change (fold)   STM                                     
  ---------- ---------------------------------------- ---------------------------------------- --------------------------------------- --------- --------- --------- --------- ------------
  I 0019     LacI Family                              -2.9                                     -1.8^†^                                 \-        1.9       1.5^†^    \-        
  I 0305     DeoR Family                              -1.7                                     -1.7^†^                                 \-        1.9       1.5^†^    \-        \[[@B31]\]
  I 0447     Leucine-Responsive Regulatory Protein    1.6                                      \-                                      \-        -2.4      -1.8      \-        
  I 0781     DNA-Directed RNA Polymerase A Subunit    2.4^†^                                   2.8                                     \-        \-        \-        \-        \[[@B34]\]
  I 1383     AraC Family                              -2.4                                     -1.5^†^                                 \-        \-        -1.7^†^   \-        
  I 1607     LuxR Family DNA Binding Domain           1.8^†^                                   3.0                                     \-        -1.5^†^   \-        \-        
  I 1631     TetR Family                              -1.9                                     -2.1                                    \-        \-        \-        \-        
  I 1700     Predicted Transcriptional Regulator      2.0                                      2.9                                     \-        \-        \-        \-        
  II 0051    LuxR Family DNA Binding Domain           -1.9                                     -2.8                                    \-        \-        \-        \-        
  II 0800    AraC Family                              1.7                                      2.2^†^                                  \-        \-        \-        \-        
  II 0854    CRP Family Transcriptional Regulator     \-                                       1.6^†^                                  \-        -1.5      -1.7      \-        
  II 0985    LacI Family                              -2.5                                     -2.7^†^                                 \-        -2.4      \-        \-        
  II 1022    IclR Family                              -1.5^†^                                  -1.8                                    \-        -1.9      -2.1      \-        
  II 1098    AraC Family                              -1.8                                     -2.8                                    \-        1.9       1.5       \-        
  I 0446     MarR Family                              1.9^†^                                   2.9                                     2.9^†^    \-        \-        \-        
  I 0518     Cold Shock Protein, CspA                 1.6                                      \-                                      -2.0^†^   1.7       \-        \-        
  I 0720     Sugar Fermentation Stimulation Protein   \-                                       -2.0                                    1.7^†^    -1.7^†^   \-        1.5^†^    
  I 0899     Phage-Related DNA Binding Protein        -1.8                                     -1.5^†^                                 -1.9^†^   1.6       \-        -2.4^†^   
  I 1098     AsnC Family                              -1.7                                     -2.0                                    -1.6^†^   -1.6      \-        \-        
  I 1291     AraC Family                              \-                                       -1.9                                    -1.7^†^   1.7       \-        \-        
  I 1641     TetR Family                              \-                                       \-                                      -2.7^†^   -1.7      -1.8      \-        
  I 1885     LysR Family                              \-                                       -1.8^†^                                 -2.3^†^   -1.6      \-        \-        
  II 0127    IclR Family                              \-                                       1.6^†^                                  \-        -1.8      \-        1.6^†^    
  II 0219    IclR Family                              -3.2                                     -5.8                                    -3.8^†^   -1.5^†^   \-        \-        
  II 0657    Transcription Elongation Factor          2.4^†^                                   3.1                                     \-        \-        \-        2.4^†^    
  II 0810    ArsR Family                              \-                                       2.0                                     \-        1.8       1.6^†^    -2.3^†^   

A (-) indicates genes excluded for technical reasons or had a fold change of less than 1.5; ^†^genes that did not pass the statistical significance test but showed an average alteration of at least 1.5-fold. Fold change values are the averaged log~2~ratio of normalized signal values from two independent statistical analyses. Abbreviations as follows: STM, Signature Tagged Mutagenesis.

The differentially expressed genes were categorized by clusters of orthologous genes (COGs), obtained from the DOE Joint Genome Institute Integrated Microbial Genomics project <http://img.jgi.doe.gov/cgi-bin/pub/main.cgi>. This classification revealed categories that were equally altered by both the *vjbR*mutant and addition of C~12~-HSL to wildtype bacteria (Fig. [3](#F3){ref-type="fig"}). For example; defense mechanisms, intracellular trafficking and secretion were highly over-represented when compared to genomic content. Of particular note, genes involved in cell division were found to be over-represented in wildtype bacteria grown in the presence of C~12~-HSL but not by deletion of *vjbR*, indicating that C~12~-HSL regulates cellular division and may play a key role in the intracellular replication of the bacteria.

![**COG functional categories found to be over and under represented by the deletion of *vjbR*and the addition of C~12~-HSL to wildtype cells, indicated by microarray analyses**. Ratios were calculated by comparing the proportion of genes found to be altered by the putative QS component to the total number of genes classified in each COG category present in the *B. melitensis*genome.](1471-2180-10-167-3){#F3}

Genes found to be altered by deletion of *vjbR*and treatment with C~12~-HSL in both wildtype and Δ*vjbR*backgrounds were compared to data compiled from random mutagenesis screenings, resulting in the identification of 61 genes (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3) \[[@B22],[@B28],[@B39]\]. This correlation strongly suggests that VjbR and C~12~-HSL are involved not only in regulating the expression of a diverse array of genes but numerous genetic loci that individually make significant contributions to the intracellular survival of *Brucella*spp.

###### 

Transcripts associated with transport significantly altered between 16M and 16MΔ*vjbR*, with and without the treatment of C~12~-HSL to cells.

  BME Loci                Gene Function                                                     Exponential Growth Phase Change fold   Stationary Growth Phase Change (fold)   STM                                     
  ----------------------- ----------------------------------------------------------------- -------------------------------------- --------------------------------------- --------- --------- --------- --------- -------------
  **Amino Acid**                                                                                                                                                                                                   
  I 0114                  ABC-Type AA Transport                                             1.6                                    2.1                                     \-        1.8       1.5^⁪^    \-        
  I 0263                  ABC-Type Leucine/Isoleucine/Valine/Threonine/Alanine Transport    -1.8^†^                                \-                                      \-        2.1       2.1       \-        
  II 0038                 D-Serine, D-Alanine, Glycine Transporter                          \-                                     -1.5^†^                                 \-        -1.6^†^   -1.8      \-        Ficht, u.p.
  II 0517                 ABC-Type Branched Chain AA Transport System, AzlC                 -1.8                                   \-                                      \-        -2.2      -1.7^†^   \-        
  II 0873                 ABC-Type High Affinity Branched Chain AA Transport System, LivF   -2.0^†^                                -2.3                                    \-        \-        -1.5^†^   \-        
  II 0909                 Glutamate, γ-Aminobutyrate Antiporter                             \-                                     \-                                      \-        -2.1      -1.7      \-        
  I 0260                  ABC-Type High-Affinity Branched Chain AA Transport, BraF          \-                                     2.1                                     \-        -1.5^†^   \-        3.0^†^    
  I 0642                  Urea Transporter                                                  -2.3^†^                                -1.9                                    2.0^†^    \-        \-        \-        
  I 1022                  ABC-Type Arginine, Ornithine Transporter                          1.7^†^                                 2.8                                     2.2^†^    \-        \-        \-        
  I 1869                  Homoserine Lactone Efflux Protein                                 \-                                     -2.3                                    -3.1^†^   -1.5^†^   \-        2.1^†^    
  II 0070                 ABC-Type Branched Chain AA Transport System                       \-                                     1.6^†^                                  \-        -2.5      -1.8^†^   1.9       
  II 0484                 ABC-Type Spermidine/Putrescine Transport System                   -2.3                                   -2.5                                    \-        \-        -2.0      -2.3^†^   
  **Carbohydrate**                                                                                                                                                                                                 
  I 1385                  ABC-Type Lactose Transport System                                 -2.6^†^                                -3.2                                    \-        \-        \-        \-        Ficht, u.p.
  II 0115                 ABC-Type G3P Transport System                                     -1.7^†^                                -3.2                                    \-        \-        \-        \-        
  II 0301                 ABC-Type Ribose Transport System, RbsC                            1.5^†^                                 \-                                      \-        -1.9      \-        \-        
  II 1096                 MFS Family, Putative Tartrate Transporter                         1.7^†^                                 2.6                                     \-        \-        \-        \-        
  I 0556                  MFS Transporter ?-Ketoglutarate Permease                          -2.4^†^                                -2.5                                    \-        \-        \-        -2.2^†^   
  II 0300                 ABC-Type Ribose Transport System, RbsA                            -1.9                                   -1.8^†^                                 \-        1.7       \-        1.6^†^    \[[@B22]\]
  II 0362                 ABC-Type Xylose Transport System, XylH                            -1.6^†^                                -2.5                                    -3.0^†^   \-        \-        \-        
  II 0700                 Galactoside Transport System, MglC                                1.6^†^                                 \-                                      -1.8^†^   -2.1      \-        5.5^†^    
  II 0701                 ABC-Type Ribose Transport System, RbsC                            2.4^†^                                 2.2                                     \-        \-        \-        2.6^†^    \[[@B33]\]
  II 0702                 ABC-Type Simple Sugar Transport System                            1.5^†^                                 \-                                      -3.6^†^   \-        -2.8      -5.1^†^   
  II 0838                 Succinoglycan Biosynthesis Transport Protein, ExoT                -2.0                                   -4.3                                    -4.2^†^   \-        -1.7      \-        
  II 0851                 Exopolysaccharide Export, ExoF Precursor                          -2.1                                   \-                                      2.1^†^    \-        \-        \-        
  **Defense Mechanism**                                                                                                                                                                                            
  I 0361                  ABC-Type Antimicrobial Peptide Transporter System, FtsX           -1.9                                   \-                                      \-        \-        -1.6^†^   \-        
  I 0472                  ABC-Type Multidrug Transport System                               \-                                     2.0                                     \-        -1.6^†^   -1.5^†^   \-        
  I 0656                  ABC-Type Multidrug Transporter                                    1.7                                    2.3^†^                                  \-        1.6^†^    \-        \-        
  I 1743                  ABC-Type Multidrug Transporter System                             \-                                     \-                                      \-        -1.8^†^   -1.7      \-        
  I 1934                  ABC-Type Oligopeptide Transport System                            -1.6^†^                                -1.9                                    \-        \-        \-        \-        
  II 0199                 ABC-Type Oligopeptide Transport System, OppF                      -1.5^†^                                -2.8                                    \-        \-        \-        \-        
  II 0205                 ABC-Type Oligo/Dipeptide Transport System, DppF                   -1.9                                   -2.1^†^                                 \-        1.6       \-        \-        
  II 0285                 ABC-Type Oligo/Dipeptide/Nickel Transport System, DppB            \-                                     \-                                      \-        1.7       1.6^†^    \-        \[[@B31]\]
  II 0473                 Cation/Multidrug Efflux Pump                                      -1.8                                   -1.5^†^                                 \-        1.8       \-        \-        
  II 0801                 ABC-Type Multidrug Transport System                               -2.3                                   \-                                      \-        -1.7      \-        \-        
  I 0187                  DME Family Transporter                                            \-                                     \-                                      -3.9^†^   -1.8      -2.2      \-        Ficht, u.p.
  I 0654                  ABC-Type Multidrug Transporter                                    -1.7                                   -2.1                                    -2.3^†^   2.0       \-        \-        
  I 0655                  ABC-Type Multidrug Transporter                                    -1.8                                   -2.3                                    \-        -1.7^†^   \-        1.5^†^    
  I 0984                  ABC-Type β -(1,2) Glucan Transporter                              -2.1                                   \-                                      1.7^†^    \-        -1.5^†^   \-        
  II 0221                 ABC-Type Oligo/Dipeptide/Nickel Transport System, DppC            \-                                     -1.9                                    -2.8^†^   -1.5^†^   \-        \-        
  II 0382                 Acriflavin Resistance Protein D                                   -1.5^†^                                \-                                      \-        -1.8      \-        1.8^†^    
  **Inorganic Ions**                                                                                                                                                                                               
  I 1041                  ABC-Type Fe-S Cluster Assembly Transporter                        1.5^†^                                 2.0                                     \-        \-        \-        \-        
  I 1954                  ABC-Type Metal Ion Transport System                               -2.0                                   -1.6                                    \-        2.0       2.1       \-        
  II 0005                 ABC-Type Molybdate-Binding Protein                                -2.7                                   -2.4                                    \-        1.8^†^    \-        \-        
  II 0418                 Mg^2+^Transporter Protein, MgtE                                   -3.2                                   -1.9^†^                                 \-        -1.6^†^   -1.8^†^   \-        
  II 0798                 ABC-Type Nitrate Transport System, NrtC                           \-                                     \-                                      \-        -2.1      -2.1      \-        
  II 0923                 ABC-Type Spermidine/Putrescine Transport System                   -1.9^†^                                -2.6                                    \-        \-        \-        \-        \[[@B22]\]
  II 1121                 ABC-Type Fe^3+^Transport System, SfuB                             \-                                     \-                                      \-        -1.8^†^   -1.9      \-        
  I 0637                  ABC-Type Cobalt Transport Protein, CbiQ                           1.5^†^                                 2.3                                     1.9^†^    -1.6^†^   \-        1.9^†^    
  I 0641                  ABC-Type Co^2+^Transport System                                   1.8^†^                                 1.9                                     \-        -1.8      \-        1.6^†^    
  I 0659                  ABC-Type Fe^3+^Siderophore Transport System                       -1.8                                   -2.0                                    \-        \-        \-        1.7^†^    
  I 1739                  ABC-Type Nitrate/Sulfonate/Bicarbonate Transporter                -1.5^†^                                -1.8                                    -1.8^†^   -1.7      -2.1      \-        
  II 0176                 ABC-Type High-Affinity Zn Transport System, ZnuB                  -2.4^†^                                -2.3                                    -1.8^†^   \-        \-        \-        
  II 0770                 Potassium Efflux System, PhaA, PhaB                               -2.0^†^                                -2.1                                    -1.6^†^   \-        \-        \-        
  **Other**                                                                                                                                                                                                        
  I 1852                  ABC-Type Heme Exporter Protein B                                  -1.8                                   -1.9                                    \-        \-        \-        \-        
  I 1860                  ABC-Type Transporter, Lysophospholipase L1                        -1.8^†^                                -1.9                                    \-        \-        \-        \-        
  I 1198                  RDD Family, Hypothetical Membrane Spanning Protein                1.5                                    1.6^†^                                  -1.7^†^   \-        \-        \-        
  I 1554                  MFS Family Transporter                                            \-                                     \-                                      \-        -2.3      -2.0      2.0^†^    
  I 1851                  ABC-Type Heme Exporter Protein C                                  \-                                     -1.9^†^                                 -1.6^†^   1.8       \-        \-        
  II 1136                 ABC-Type Uncharacterized Transport System                         -1.5^†^                                -1.9                                    -2.2      \-        \-        \-        

A (-) indicates genes excluded for technical reasons or had a fold change of less than 1.5; ^†^genes that did not pass the statistical significance test but showed an average alteration of at least 1.5-fold. Fold change values are the averaged log~2~ratio of normalized signal values from two independent statistical analyses. Abbreviations are as follows: STM, Signature Tagged Mutagenesis; DME, Drug/Metabolite Exporter; G3P, Glycerol-3-Phosphate; AA, amino acid.

###### 

Genetic loci transcripts significantly altered between 16M and 16MΔ*vjbR*, with or without the treatment of C~12~-HSL that may contribute to virulence.

  BME Loci                       Gene Function                                                                         Exponential Growth Phase Change (fold)   Stationary Growth Phase Change (fold)   STM                                     
  ------------------------------ ------------------------------------------------------------------------------------- ---------------------------------------- --------------------------------------- --------- --------- --------- --------- ---------------------------------
  **Cell Membrane**                                                                                                                                                                                                                             
  I 1873                         Autotransporter Adhesin                                                               -2.2                                     \-                                      \-        \-        \-        \-        
  II 1069                        Adhesin, AidA                                                                         -1.5^†^                                  \-                                      \-        -1.5      \-        \-        
  I 0402                         31 KDa OMP Precursor                                                                  \-                                       1.5^†^                                  \-        -1.7      -1.7^†^   \-        
  I 0330                         OpgC Protein                                                                          \-                                       -2.0                                    -1.9^†^   \-        \-        \-        
  I 0671                         Integral Membrane Protein, Hemolysin                                                  \-                                       -2.7                                    -2.2^†^   \-        \-        \-        \[[@B28]\]
  II 1070                        Adhesin AidA-I                                                                        1.7                                      \-                                      \-        \-        \-        -1.9^†^   
  I 1304                         Porin, F Precursor                                                                    \-                                       \-                                      -3.6^†^   -3.5      -2.0      -2.6^†^   
  I 1305                         Porin                                                                                 \-                                       -2.3                                    -1.8^†^   -1.5^†^   \-        \-        
  **Cell Motility**                                                                                                                                                                                                                             
  II 0151                        Flagellar M-Ring Protein, FliF                                                        -2.2                                     -2.1                                    \-        2.1^†^    \-        \-        \[[@B22],[@B34]\]
  II 0161                        Flagellar Hook-Associated Protein 3                                                   -1.8^†^                                  -2.7                                    \-        \-        \-        \-        
  II 0165                        Flagellar Biosynthesis Protein                                                        -1.9^†^                                  -2.8                                    \-        \-        \-        \-        
  I 1692                         Flagellar Protein, FlgJ                                                               \-                                       \-                                      -2.3^†^   -1.8      -2.1      -3.4^†^   
  II 0160                        Flagellar Hook-Associated Protein, FlgK                                               -1.6^†^                                  -2.0                                    -1.7^†^   \-        \-        \-        
  II 0162                        FlaF Protein                                                                          -2.1                                     -2.0^†^                                 \-        \-        \-        -1.6^†^   
  II 0167                        Flagellar Biosynthesis Protein, FlhA                                                  -1.6^†^                                  -2.3                                    -1.8^†^   -1.5^†^   -1.9^†^   -5.5^†^   
  II 1109                        Chemotaxis Protein, MotA                                                              -1.6^†^                                  2.0^†^                                  -3.6^†^   -1.7      -1.5^†^   \-        
  **Protease and Lipoprotein**                                                                                                                                                                                                                  
  I 0611                         HflC Protein, Stomatin, Prohibitin, Flotillin, HflK-C Domains                         -1.6                                     \-                                      \-        \-        -1.7^†^   \-        
  I 1079                         Lipoprotein NlpD                                                                      \-                                       -1.5^†^                                 -1.6^†^   -1.6^†^   -1.9      \-        
  I 1799                         Lipoprotein Signal Peptidase                                                          2.2                                      2.1^†^                                  \-        \-        -1.6^†^   \-        
  II 0831                        Hypothetical Protein, Aminopeptidase-Like Domain                                      -1.6^†^                                  -2.0                                    \-        -2.3      \-        3.1^†^    
  I 0213                         Metalloendopeptidase                                                                  -1.7^†^                                  -2.7^†^                                 -1.6^†^   2.1       \-        \-        
  I 0282                         Zinc Metalloprotease                                                                  -1.8                                     -1.7                                    \-        \-        \-        3.4^†^    
  II 0149                        Extracellular Serine Protease                                                         -3.2                                     -1.8                                    2.9^†^    \-        -1.7      \-        
  **Secretion System**                                                                                                                                                                                                                          
  I 0390                         VceA                                                                                  -1.4^†^                                  -1.3^†^                                 \-        \-        -1.2^†^   \-        
  I 0948                         VceC                                                                                  1.1^†^                                   1.4^†^                                  \-        1.6^†^    1.3^†^    \-        
  I 1094                         Exopolysaccharide Production Negative Regulator Precursor, Tetratricopeptide Repeat   \-                                       \-                                      \-        2.1       1.5^†^    \-        
  I 1141                         Predicted Exported Protein                                                            -1.6                                     -1.7                                    \-        \-        \-        \-        
  I 1531                         Tetratricopeptide Repeat Family Protein                                               -2.1                                     -2.4                                    \-        -1.7      \-        \-        \[[@B34]\]
  I 1077                         Hypothetical Exported Protein, YajC                                                   -1.5                                     -2.1                                    \-        -1.8^†^   -1.5^†^   1.8^†^    
  II 0025                        Attachment Mediating Protein VirB1                                                    -2.2                                     -1.9                                    \-        -2.6      -2.2      \-        \[[@B29],[@B31],[@B36]\]
  II 0026                        Attachment Mediating Protein VirB2                                                    \-                                       -2.1                                    \-        -4.3      -3.6      -1.3^†^   \[[@B29],[@B31],[@B36]\]
  II 0027                        Channel Protein VirB3                                                                 \-                                       \-                                      \-        -3.9      -3.2      \-        \[[@B29]-[@B31],[@B36]\]
  II 0029                        Attachment Mediating Protein VirB5                                                    -2.0                                     \-                                      1.6^†^    -5.7      -4.5      -1.2^†^   \[[@B29]-[@B32]\]
  II 0030                        Channel Protein VirB6                                                                 \-                                       \-                                      -1.7^†^   -2.8      -2.3      \-        \[[@B29]-[@B31],[@B36]\]
  II 0032                        Channel Protein VirB8                                                                 -1.6^†^                                  \-                                      1.1^†^    -3.3      -2.6      \-        \[[@B29],[@B31],[@B32],[@B36]\]
  II 0033                        Channel Protein VirB9                                                                 \-                                       \-                                      \-        -1.8      -1.9      \-        \[[@B29],[@B31],[@B36]\]
  II 0034                        Channel Protein VirB10                                                                \-                                       -1.5                                    \-        -2.0      -1.9      \-        \[[@B29],[@B31],[@B36]\]
  II 0036                        OMP, OprF, VirB12                                                                     \-                                       \-                                      \-        -1.7      -1.7      \-        \[[@B29],[@B36]\]
  II 0466                        Tetratricopeptide Repeat Family Protein                                               \-                                       2.3                                     2.2^†^    -1.5^†^   \-        \-        
  **Signal Transduction**                                                                                                                                                                                                                       
  II 0011                        Transcriptional Regulatory Protein, HydG                                              -1.5^†^                                  -2.0                                    \-        \-        \-        \-        \[[@B31]\]
  II 1014                        Two Component Response Regulator                                                      \-                                       1.7^†^                                  \-        1.6       -1.5^†^   \-        
  I 0370                         Sensory Transduction Histidine Kinase                                                 -1.7                                     -2.1                                    -2.2^†^   -1.6^†^   \-        2.1^†^    
  I 0372                         Two-Component Response Regulator                                                      1.6^†^                                   \-                                      -1.5^†^   1.5^†^    1.8       \-        
  I 2034                         Sensor Protein, ChvG                                                                  \-                                       -1.7                                    -2.4^†^   -2.0      -1.6      \-        
  **Stress Response**                                                                                                                                                                                                                           
  I 0887                         Peptidyl-Prolyl Cis-Trans Isomerase                                                   \-                                       -1.7                                    \-        1.7       1.6       \-        
  I 1619                         Hsp33-Like Chaperonin                                                                 \-                                       \-                                      \-        1.8       1.6^†^    \-        
  II 0245                        Universal Stress Protein Family, UspA                                                 -1.8                                     -1.7                                    -2.0^†^   -2.5      -2.5      \-        

A (-) indicates genes excluded for technical reasons or had a fold change of less than 1.5; ^†^genes that did not pass the statistical significance test but showed an average alteration of at least 1.5-fold. Fold change values are the averaged log~2~ratio of normalized signal values from two independent statistical analyses. Abbreviations are as follows: STM, Signature Tagged Mutagenesis; OMP, Outer Membrane Protein.

VjbR and C~12~-HSL modulate gene transcription in a temporal manner
-------------------------------------------------------------------

Comparison of altered gene transcripts resulting from the Δ*vjbR*mutation revealed that 13% (54 statistically significant genes) were found to be regulated at both growth phases, suggesting that VjbR exerts temporal control over gene regulation (Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). A similar subset of genes were also identified in wildtype bacteria that were treated with C~12~-HSL when compared to those without treatment, with 12% (54 genes, Additional File [3](#S3){ref-type="supplementary-material"}, Table S3) of transcripts altered at both growth stages. The low correlation of genes altered at both growth stages suggests that both VjbR and C~12~-HSL regulate distinct regulons at the two growth stages examined.

A recent study compared microarray and proteomic data from a Δ*vjbR*mutant at a late exponential growth phase (OD~600~= 0.75), corresponding to a total of 14 genes and the *virB*operon found at the growth phases examined here \[[@B23]\]. Of the 14 genes in common with the study by Uzureau et al.; 2 genes and the *virB*operon identified in our study (BMEI1435 and I1939) correlated in the magnitude of change with both the protein and microarray data, BMEI1267 correlated with the protein data, and 3 genes (BMEI1900, II0358 and II0374) correlated with the microarray data (Additional File [3](#S3){ref-type="supplementary-material"}, Table S3) \[[@B23]\]. Additionally, 5 genes did not correspond with the magnitude of alteration in the microarray analyses conducted in this study (BMEI0747, I1305, I1367, II0098 and II0923; Table [3](#T3){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3) \[[@B23]\]. The low similarity of regulated genes from these two studies that examined a total of 3 different growth phases provides further support of the VjbR temporal gene regulation observed here \[[@B23]\].

A similar pattern of temporal gene regulation by AHL quorum sensing signals has also been observed in *P. aeruginosa*\[[@B26],[@B40]\]. Distinct regulons were identified at an exponential and early stationary growth phase by utilization of a mutated strain that does not produce AHL signals, leading to the conclusion that the temporal regulation is independent of AHL concentration \[[@B26],[@B40]\]. Examination of two *luxR*gene transcript levels in *P. aeruginosa*revealed an increase from the late logarithmic to early stationary phase, coinciding with the induction of most quorum-activated genes and supporting a hypothesis that the receptor levels govern the onset of induction \[[@B40]\]. Likewise, the relative expression of *B. melitensis vjbR*was found to increase 25-fold from exponential to stationary growth phase by qRT-PCR (Fig. [4](#F4){ref-type="fig"}). The observed increase in the transcript levels of *vjbR*supports a similar hypothesis for the temporal gene regulation observed by VjbR in *B. melitensis*

![**Relative expression of *vjbR*transcript over time. Taqman real-time RT-PCR of *vjbR*in *B. melitensis*16M expressed as the mean relative concentration (to 16srRNA) from 3 biological replicates ± standard deviation**. Filled blue squares represent the relative expression of *vjbR*and the open light blue squares represent the OD~600~of corresponding cultures. The exponential growth stage for microarray analysis corresponds to OD~600~= 0.4 (14 hrs) and the stationary growth phase corresponds to OD~600~= 1.5 (28 hrs).](1471-2180-10-167-4){#F4}

VjbR and C~12~-HSL alter expression of a common set of genes
------------------------------------------------------------

To examine the relationship between VjbR and C~12~-HSL gene regulation, the significantly altered genes from the VjbR regulon were compared to the significantly altered genes from the C~12~-HSL regulon (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). In all, 72 genes were found to be co-regulated during the exponential growth phase and 55 genes at the stationary growth phase, representing approximately 20% of the total number of altered genes identified by microarray analysis. The majority of the common, differently expressed transcripts (124 out of 127) were found to be altered in the same direction by both the *vjbR*mutant and in response to C~12~-HSL administration, implying that VjbR and C~12~-HSL exert inverse effects on gene expression.

In addition to the T4SS and flagella operons being inversely co-regulated, T4SS-dependent effector proteins VceA and VceC were also found to be inversely regulated by the *vjbR*deletion mutant and addition of C~12~-HSL to wildtype cells, as well as exopolysaccharide production, proteases, peptidases and a universal stress protein (Table [4](#T4){ref-type="table"}). Flagellar and exopolysaccharide synthesis genes have been implicated in the intracellular survival of *Brucella*in mice and macrophages \[[@B4],[@B41]\]. The down-regulation of these factors in *vjbR*mutants and in response to C~12~-HSL suggests that VjbR promotes *Brucella*virulence; while conversely, C~12~-HSL represses such gene expression, either through the same regulatory pathway or independently.

These results expand on earlier findings that C~12~-HSL represses transcription of the T4SS through interactions with the response domain of VjbR \[[@B17],[@B42]\]. The genes identified as co-regulated between VjbR and C~12~-HSL may be the result of C~12~-HSL reducing VjbR transcriptional activity through the AHL binding domain. Additionally, the observation that the expression of *vjbR*itself was down-regulated at the stationary growth phase in response to C~12~-HSL administration further supports a non-cooperative relationship between VjbR and C~12~-HSL, (2.9-fold by qRT-PCR and 1.2-fold by microarray analysis, Table [1](#T1){ref-type="table"}).

Physiological characterization of VjbR and C~12~-HSL transcriptomes
-------------------------------------------------------------------

*Virulence*. Microarray results confirmed alteration of the previously identified T4SS and flagellar genes, both virulence-associated operons found to be regulated by VjbR and/or C~12~-HSL, as well as genes with homology to the recently identified T4SS effector proteins in *B. abortus*and *B. suis*\[[@B14],[@B27]\]. Furthermore, many putative virulence factors not previously correlated with VjbR or C~12~-HSL regulation in *Brucella*spp. were identified; including protein secretion factors, adhesins, lipoproteins, proteases, outer membrane proteins, antibiotic and toxin resistance genes, stress survival genes and genes containing tetratricopeptide repeats (Tables [2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}, [4](#T4){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). Many of these gene products have been found to be associated with virulence and infection in numerous other bacterial pathogens have not been studied in *Brucella*spp., calling for further investigation and characterization.

A BLAST search of the T4SS effector protein VceA against *B. melitensis*16M revealed two genes with high and low degrees of similarity, BMEI0390 and BMEII1013, with 98.8% and 35% (respectively) amino acid similarity. *VceA*(BMEI0390) was found to be down-regulated at the exponential growth phase by the *vjbR*deletion mutant and the addition of C~12~-HSL (1.4-fold and 1.3 fold) but was not statistically significant nor met the cut-off value of 1.5-fold (Table [4](#T4){ref-type="table"}). Additionally, a BLAST search of VceC revealed a gene with 99% amino acid similarity, BMEI0948, which was found to be up-regulated by Δ*vjbR*and treatment of C~12~-HSL in wildtype cells at the stationary growth phase (1.6 and 1.3-fold, respectively, Table [4](#T4){ref-type="table"}). The *vceC*homologue, which is located downstream of a confirmed VjbR promoter sequence, was unexpectedly found to be down-regulated by VjbR and not up-regulated along with the T4SS (*virB*operon) \[[@B27]\]. Expression of *vceA*was found to be promoted at the exponential growth phase by VjbR, however, no information was obtained at the stationary growth phase for comparison to *virB*in this global survey.

Deletion of *vjbR*resulted in the down-regulation of a gene locus that encodes for the ATP-binding protein associated with the cyclic β-(1,2) glucan export apparatus (BMEI0984, 2.1-fold) and an exopolysaccharide export gene *exoF*(BMEII0851, 2.1-fold) at the exponential growth phase; while the treatment of C~12~-HSL in the Δ*vjbR*null background up-regulated these same genes 1.7 and 2.1-fold, respectively, (Table [3](#T3){ref-type="table"}). Additionally, C~12~-HSL was found to down-regulate expression of *opgC*(BMEI0330), responsible for substitutions to cyclic β-(1,2) glucan, 2.0 and 1.9-fold at the exponential growth phase in the wildtype and Δ*vjbR*backgrounds (respectively, Table [4](#T4){ref-type="table"}) \[[@B43]\]. Cyclic β-(1,2) glucan is crucial for the intracellular trafficking of *Brucella*by diverting the endosome vacuole from the endosomal pathway, thus preventing lysosomal fusion and degradation and favoring development of the brucellosome \[[@B4]\]. Mutations in the *vjbR*locus do not appear to have a profound effect on trafficking diversion from the early endosomal pathway; however, it is plausible that cyclic β-(1,2) glucan and derivatives may be important for subsequent vacuole modulation and/or brucellosome maintenance during the course of infection \[[@B14]\].

Deletion of *vjbR*resulted in alteration in the expression of three adhesins: *aidA*(BMEII1069, down-regulated 1.5-fold at both growth stages examined), *aidA*-1 (BMEII1070, up-regulated 1.7-fold) at the exponential growth phase, and a gene coding for a cell surface protein (BMEI1873, down-regulated 2.2-fold) at the exponential growth phase (Table [4](#T4){ref-type="table"}). Adhesins can serve as potent biological effectors of inflammation, apoptosis and cell recognition, potentially contributing to the virulence and intracellular survival of *Brucella*spp. \[[@B44]-[@B46]\]. For instance, AidA adhesins are important for *Bordetella pertussis*recognition of host cells and in discriminating between macrophages and ciliated epithelial cells in humans \[[@B45]\].

*Transporters*. A large number of genes encoding transporters (90 total) were altered in Δ*vjbR*or in response to the addition of C~12~-HSL to wildtype cultures (Table [3](#T3){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). For example, an exporter of O-antigen (BMEII0838) was identified to be down-regulated 2.0-fold by the deletion of *vjbR*at an exponential growth phase, and 4.3 and 1.7-fold by the addition of C~12~-HSL to wildtype cells at exponential and stationary growth phases, respectively (Table [3](#T3){ref-type="table"}). Among the differently expressed transporters, ABC-type transporters were most highly represented, accounting for 62 out of the 90 transporter genes (including 15 amino acid transporters, 10 carbohydrate transporters and 16 transporters associated with virulence and/or defense mechanisms) (Table [3](#T3){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). The correlation between ABC transporters and the ability to adapt to different environments is in tune with the ability of *Brucella*spp. to survive in both extracellular and intracellular environments \[[@B47]\].

*Transcription*. Based on microarray analysis results, *vjbR*deletion or the addition of C~12~-HSL to wildtype cells altered the expression of 42 transcriptional regulators, comprised of 12 families and 14 two-component response regulators or signal transducing mechanisms (Table [2](#T2){ref-type="table"} and Additional File [3](#S3){ref-type="supplementary-material"}, Table S3). Among the transcriptional families altered by Δ*vjbR*and/or the addition of C~12~-HSL, 9 families (LysR, TetR, IclR, AraC, DeoR, GntR, ArsR, MarR and Crp) have been implicated in the regulation of virulence genes in a number of other pathogenic organisms \[[@B35],[@B48]-[@B55]\]. The regulation of *virB*has been reported to be influenced not only by the deletion of *vjbR*and C~12~-HSL treatment, but by several additional factors including integration host factor (IHF), BlxR, a stringent response mediator Rsh, HutC, and AraC (BMEII1098) \[[@B14],[@B15],[@B56]-[@B58]\]. The same AraC transcriptional regulator was found to altered by *vjbR*deletion and C~12~-HSL treatment of wildtype cells: down-regulated 1.8 and 2.8-fold at exponential phase (respectively), and up-regulated 1.9 and 1.5-fold (respectively) at the stationary growth phase (Table [2](#T2){ref-type="table"}). Additionally, HutC (BMEII0370) was also found to be down-regulated at the exponential growth phase by the Δ*vjbR*mutant (1.8-fold), suggesting several levels of regulation for the *virB*operon by the putative QS components in *B. melitensis*(Additional File [3](#S3){ref-type="supplementary-material"}, Table S3).

In addition to transcriptional regulators linked to virulence, microarray analyses also revealed two differentially expressed transcriptional regulators that contain the LuxR HTH DNA binding pfam domain (gerE, pfam00196). Gene transcript BMEII0051 was found to be down-regulated 1.9 and 2.8-fold in response to a *vjbR*deletion and addition of C~12~-HSL to wildtype cells (respectively) at an exponential growth phase (Table [2](#T2){ref-type="table"}). This *luxR*-like gene is located downstream of a VjbR consensus promoter sequence and thus most likely directly promoted by VjbR \[[@B27]\]. The second *luxR*-like gene, BMEI1607, was up-regulated 1.8-fold and 3.0-fold in the *vjbR*mutant and in response to exogenous C~12~-HSL at the exponential growth phase (respectively), and down-regulated 1.5-fold by the deletion of *vjbR*at the stationary growth phase (Table [2](#T2){ref-type="table"}). This gene locus was not found to be located downstream of a predicted VjbR promoter sequence and may or may not be directly regulated by VjbR. Additionally, *blxR*was found to be induced 27.5-fold in wildtype cells treated with C~12~-HSL at the stationary growth phase by qRT-PCR (Table [1](#T1){ref-type="table"}). Likewise, qRT-PCR verified a 2.9-fold down-regulation of *vjbR*in wildtype cells supplied with exogenous C~12~-HSL at the stationary growth phase. The identification and alteration of genes containing the HTH LuxR DNA binding domain by Δ*vjbR*and C~12~-HSL administration, particularly one located downstream of the VjbR consensus promoter sequence, is of great interest. These observations potentially suggest a hierarchical arrangement of multiple transcriptional circuits which may or may not function in a QS manner, as observed in organisms such as *P. aeruginosa*\[[@B26]\].

*AHL synthesis*. The deletion of *vjbR*or addition of C~12~-HSL resulted in alteration in the expression of 15 candidate AHL synthesis genes, based on the gene product\'s potential to interact with the known metabolic precursors of AHLs, S-adenosyl-L-methionine (SAM) and acylated acyl carrier protein (acyl-ACP) (Additional File [2](#S2){ref-type="supplementary-material"}, Table S2) \[[@B59]\]. An *E. coli*expression system was utilized because *B. melitensis*has been shown to produce an AiiD-like lactonase capable of inactivating C~12~-HSL \[[@B60]\]. Cross streaks with *E. coli*AHL sensor strains and clones expressing candidate AHL synthesis genes failed to induce the sensor stains, while positive control *E. coli*clones expressing *rhlI*and *lasI*from *P. aeruginosa*and exogenous 3-oxo-C~12~-HSL did in fact induce the sensor strains (data not shown) \[[@B61]\].

C~12~-HSL regulates gene expression independent of VjbR
-------------------------------------------------------

In addition to the investigation on the influences of a *vjbR*deletion or addition of C~12~-HSL to wildtype bacteria on gene expression, treatment of Δ*vjbR*with exogenous C~12~-HSL was also assessed by microarray analyses. Compared to untreated wildtype cells, 87% fewer genes were identified as differentially altered in response to C~12~-HSL in the *vjbR*null background as opposed to wildtype cells administered C~12~-HSL. In the absence of VjbR, exogenous C~12~-HSL altered the expression of 82 genes; 34 at the exponential growth phase and 48 genes at the stationary growth phase (Fig. [2](#F2){ref-type="fig"}, red circles and Additional File [5](#S5){ref-type="supplementary-material"}, Table S5). Of these 82 statistically significant altered transcripts, only 4 were commonly altered with the same magnitude by a deletion of *vjbR*or wildtype cells treated with C~12~-HSL (Fig. [2](#F2){ref-type="fig"}). At the exponential growth phase, administration of C~12~-HSL exerted an equal effect on gene expression, up and down-regulating 19 and 23 genes (respectively, Fig. [2](#F2){ref-type="fig"}). On the contrary, at the stationary phase all 48 genes were up-regulated, a dramatically different profile than the down-regulation observed for the majority of differently expressed genes in C~12~-HSL treated wildtype cells (Fig. [2](#F2){ref-type="fig"}). Collectively, this data supports that C~12~-HSL is capable of influencing gene expression independent of VjbR.

There is evidence that C~12~-HSL may interact with a second LuxR homologue, BlxR \[[@B18]\]. Induction of *blxR*expression in response to C~12~-HSL was highly variable by microarray analysis; however, qRT-PCR revealed that *blxR*was up-regulated 99.5-fold in bacteria lacking *vjbR*treated with C~12~-HSL, compared to 27.5-fold in wildtype cells that were administered C~12~-HSL at the stationary growth phase. One possible explanation for this observation is that VjbR inhibits the induction of *blxR*by binding the AHL substrate and therefore lowering the cellular concentration of available C~12~-HSL for *blxR*induction, but has not been demonstrated.

Interestingly, 58% of the gene transcripts found to be altered in an recent study of the function of Δ*blxR*were also found to be altered by the addition of C~12~-HSL in the Δ*vjbR*background, and increased to 88% if we lowered the threshold from our 1.5-fold cutoff (Additional File [5](#S5){ref-type="supplementary-material"}, Table S5) \[[@B15]\]. A second study that similarly examined the transcript and proteomic alterations due to a deletion in *babR*corresponded with 6 genes identified in our study: with 2 genes found to be unique to the addition of C~12~-HSL in the Δ*vjbR*background (BMEI0231 and I1638, Additional File [5](#S5){ref-type="supplementary-material"}, Table S5), and 4 genes additionally altered by the deletion of *vjbR*or addition of C~12~-HSL in the wildtype background (BMEI0451, I0712, I1196 and II0358, Additional File [3](#S3){ref-type="supplementary-material"}, Table S3) \[[@B23]\]. Although many of these genes were not statistically significant in our analyses, this is a strikingly high correlation since the same conditions were not examined (Δ*blxR*vs. wt compared to Δ*vjbR*vs. Δ*vjbR*+ C~12~-HSL), as well as the use of differing microarray platforms and analyses procedures. This connection may suggest that the genes altered by the presence of C~12~-HSL in the absence of VjbR may be due to C~12~-HSL activation of BlxR.

Conclusions
===========

The goal of this work was to provide an elementary understanding in the role of the putative QS components in the virulence and survival of *B. melitensis*. VjbR is a homologue of LuxR, a transcriptional regulator previously shown to interact with an AHL signal C~12~-HSL and modulate expression of transcripts required for intracellular survival \[[@B14],[@B17]\]. Custom *B. melitensis*microarrays were utilized to examine the regulons controlled by VjbR and C~12~-HSL, revealing a large number of genes potentially involved in the virulence and intracellular survival of the organism. Such genes include adhesins, proteases, lipoproteins, a hemolysin, secretion system components and effector proteins, as well as metabolic genes involved in energy production, amino acid, carbohydrate, and lipid metabolism. Furthermore, deletion of *vjbR*and C~12~-HSL treatment altered the expression of genes coding for components involved in the transport of numerous substrates across the cell membrane.

The microarray analyses conducted in this study also confirmed previous findings that *fliF*and the *virB*operon are regulated by Δ*vjbR*and exogenous C~12~-HSL treatment at an exponential growth phase and stationary growth phase (respectively), as well as the potential effector proteins VceA and VceC, validating the microarray approach to identify additional genes regulated by these putative QS components \[[@B14],[@B27]\]. The contribution of VjbR gene regulation at different growth phases in not fully understood, but microarray analyses suggests that there are distinct sets of genes regulated at both growth phases in addition to the flagellar and T4SS operons. Previous studies examining the effect of timing on QS related genes in *P. aeruginosa*hypothesized that the transcriptional regulator and not the inducing or repressing signal is responsible for the continuum of responses observed \[[@B40]\]. Such a hypothesis is supported by the observed increase of *vjbR*expression over time in *B. melitensis*.

Deletion of *vjbR*and treatment of C~12~-HSL both resulted in a global modulation of gene expression. Examination of the relationship in respect to the genes commonly altered between Δ*vjbR*and wildtype bacteria administered C~12~-HSL suggests that C~12~-HSL reduces VjbR activity, based upon the following observations: 1) An inverse correlation in gene expression for all but three genes found to be altered by VjbR and C~12~-HSL, 2) Addition of exogenous C~12~-HSL to growth media mimics the deletion of VjbR in respect to gene alteration, 3) In the absence of *vjbR*, C~12~-HSL treatment has a markedly different effect on gene expression at the stationary growth phase, found to only promote gene expression, and 4) *virB*repression in response to the addition of C~12~-HSL is alleviated by deletion of the response receiver domain of VjbR \[[@B17]\]. The observed promotion of gene expression with the treatment of C~12~-HSL in a Δ*vjbR*background could potentially be occurring through a second LuxR-like protein BlxR, supported by the high correlation of commonly altered genes by Δ*blxR*and Δ*vjbR*with the addition of C~12~-HSL in independent studies \[[@B15],[@B23]\]. Often, the LuxR transcriptional regulator and AHL signal form a positive feedback loop, increasing the expression of *luxR*and the AHL synthesis gene \[[@B62]\]. The observed up-regulation of *blxR*by C~12~-HSL may be an example of such a feedback loop, further supporting an activating role C~12~-HSL and BlxR activity.

Although evidence is indirect, these observations suggest that there may be two dueling transcriptional circuits with the LuxR transcriptional regulators (VjbR and BlxR). C~12~-HSL may provide a level of regulation between the two systems, deactivating VjbR and potentially activating BlxR activity during the transition to stationary phase. It appears that C~12~-HSL reduces VjbR activity, alters expression of 2 additional transcriptional regulators that contain the LuxR DNA binding domain, induces expression of BlxR and potentially activates gene expression through interactions with BlxR. It would be interesting to determine if the decrease in *virB*expression observed in wildtype cells at stationary phase is a result of C~12~-HSL accumulation and subsequent \"switching\" of transcriptional circuits *in vitro*\[[@B63]\]. Further experiments are needed to fully understand the temporal regulation of VjbR and associations with C~12~HSL, as well as indentification of AHL synthesis gene(s) in *Brucella*spp.

The role of the LuxR transcriptional regulators VjbR and BlxR and the AHL signal in relation to quorum sensing has not been fully deduced. Continuing investigation of these putative QS components *in vitro*and *in vivo*will help determine if these components work in a QS-dependent manner in the host cell or if they function more in a diffusion or spatial sensing context to allow differentiation between intracellular and extracellular environments \[[@B64]\]. Future experiments that elucidate how these processes contribute to the \"stealthiness\" of *Brucellae*and will provide additional clues to the intracellular lifestyle of this particular bacterium.
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